Larvol Delta - Biomind-Labs-Announces-the-Completion-of-the-First-Sublingual-Psychedelic-Formulation-for-Its-Drug-Candidate-BMND08-for-Depression-and-Anxiety-in-Alzheimers-Disease

5-methoxy-N,N-dimethyltryptamine (BMND08) - Biomind

https://www.businesswire.com/news/home/20221228005258/en/Biomind-Labs-Announces-the-Completion-of-the-First-Sublingual-Psychedelic-Formulation-for-Its-Drug-Candidate-BMND08-for-Depression-and-Anxiety-in-Alzheimer%E2%80%99s-Disease

Dec 28, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next